Stock Alert: Cyclo Therapeutics Adds 20% Following Positive Data From Drug Candidate

Shares of Cyclo Therapeutics, Inc. (CYTH) are up more than 20% Tuesday morning after the company announced the presentation of positive data from the early stage studies of its lead drug candidate, Trappsol Cyclo in Niemann-Pick Disease Type C at the World Symposium 2021.

Niemann-Pick Disease Type C is a rare genetic disorder causing cholesterol accumulation in lysosomes of cells, organ dysfunction and premature death.

Data from the ongoing Phase 1 extension study showed improvement in disease features or disease stabilization with home-based intravenous infusions of Trappsol Cyclo.

The Interim analysis of Phase 1/2 study showed Trappsol Cyclo has favorable safety profile and encouraging signals in efficacy.

Phase 1/2 study is estimated to be completed in February 2021 with top line results expected in the first quarter of 2021.

The company plans to commence enrollment in pivotal Phase 3 study in the second quarter of 2021.

CYTH, currently at $13.50, has been trading in the range of $3.40- $30 in the last one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Editors Pick
Tesla CEO Elon Musk announced that the luxury electric vehicle maker has started the production of Tesla Semi electric trucks, and the first delivery will be to food and beverages giant Pepsico Inc. starting December 1. In a tweet, Musk said, "Excited to announce start of production of Tesla Semi Truck with deliveries to @Pepsi on Dec 1st!" Ford Motor is increasing the entry-level price of its electric F-150 Lightning pickup citing rising costs and supply chain issues amid increasing demand. This is the second price hike after a recent increase in August. The starting price of the 2023 model year pickup will be raised by $5,000 by October 24, reports said citing an email statement. Constellation Brands, Inc. (STZ) said it delivered another quarter of strong business performance. Beer Business achieved double-digit net sales growth for the quarter, while Wine and Spirits net sales rose 1%. The solid top-line performance of its Beer and Wine and Spirits Businesses in the first half...
Follow RTT